Animal Antibiotics and Antimicrobials Market - By Product Type (Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins), By mode of delivery, Animal Type & Global Forecast 2023-2032

List of Tables

Global Animal Antibiotics and Antimicrobials Market could grow significantly over 2023-2032, driven by the rising consumption and uptake of animal-based proteins.

The increasing global demand for animal-derived protein products, coupled with the growing population, has led to a rise in intensive animal farming practices, thereby increasing the risk of disease outbreaks. This necessitates using antibiotics and antimicrobials to prevent and treat infections in livestock, which will propel market revenue in the long run. The rising prevalence of zoonotic diseases and the need for disease control measures further contribute to market growth.

According to CDC, scientists estimate that over 6 out of every 10 known infectious illnesses in humans can be transmitted from animals, and 3 out of every 4 new or emerging infectious diseases in people spread from animals. Additionally, favorable government regulations promoting the judicious use of antibiotics and the implementation of strict guidelines for animal health management play a crucial role in shaping the market.

The overall animal antibiotics and antimicrobials market is segregated based on product, mode of delivery, animal, and region.

In terms of product, the market share from the penicillin segment will expand at a decent CAGR from 2023 to 2032. The demand for penicillin is growing due to its effectiveness in treating a wide range of bacterial infections. Penicillin is considered a first-line antibiotic and is highly effective against various bacteria, including streptococci and staphylococci. Besides, the rise of antibiotic-resistant bacteria has created a need for potent antibiotics like penicillin, further driving its demand in the medical field.

Based on the mode of delivery, the animal antibiotics and antimicrobials market size from the oral solutions segment will register appreciable growth over 2023-2032. Oral solutions offer convenient administration and are effective in treating and preventing infections in livestock. Moreover, they enable precise dosage control and facilitate the treatment of large groups of animals, making them a preferred choice for veterinary professionals and livestock farmers. The ease of oral administration and the potential for improved animal health outcomes contribute to the increasing demand for these products in the animal agriculture industry.

With respect to animal, the livestock animal segment will amass a notable share of the animal antibiotics and antimicrobials industry by 2032, attributed to the rising global demand for animal protein products. As intensive farming practices become more prevalent, the risk of disease outbreaks increases, necessitating the use of antibiotics and antimicrobials to prevent and treat infections. Effective disease control measures and improved animal health outcomes drive the demand for these products in the livestock industry.

Regionally, the Asia Pacific animal antibiotics and antimicrobials will accumulate appreciable gains through 2032. Rapid urbanization and the expanding middle class are leading to increased consumption of animal protein, driving the need for effective disease prevention and treatment in livestock. Additionally, the rise of intensive farming practices and the growing awareness of animal health and welfare contribute to the rising demand for these products in the region.

Product Code: 5608

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data Sources
- 1.4.1 Secondary
  - 1.4.1.1 Paid sources
  - 1.4.1.2 Public sources
- 1.4.2 Primary

Chapter 2 Executive Summary

2.1 Animal antibiotics and antimicrobials 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Mode of delivery trends
2.6 Animal type trends

Chapter 3 Animal Antibiotics and Antimicrobials Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Incresing demand for animal derived food products
  - 3.2.1.2 Rising concerns regarding the health of animals
  - 3.2.1.3 Growing incidences of diseases in animals
  - 3.2.1.4 Rising adoption of companion animals
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent approval process for antimicrobial and antibiotics
  - 3.2.2.2 Increasing resistance to antibiotic
3.3 Growth potential analysis
- 3.3.1 By product type
- 3.3.2 By mode of delivery type
- 3.3.3 By animal type
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
3.6 Industry ecosystem
3.7 Technology landscape
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Animal Antibiotics and Antimicrobials Market Size and Forecast, By Product Type (USD Million)

5.1 Key trends, by product type
5.2 Tetracyclines
5.3 Penicillins
5.4 Sulfonamides
5.5 Macrolides
5.6 Aminoglycosides
5.7 Lincosamides
5.8 Fluoroquinolones
5.9 Cephalosporins
5.10 Other antibiotics and antimicrobials

Chapter 6 Animal Antibiotics and Antimicrobials Market Size and Forecast, By Mode of Delivery (USD Million)

6.1 Key trends, by mode of delivery
6.2 Premixes
6.3 Oral Solutions
6.4 Oral Powders
6.5 Injections

Chapter 7 Animal Antibiotics and Antimicrobials Market Size and Forecast, By Animal Type (USD Million)

7.1 Key trends, by animal type
7.2 Companion Animal
- 7.2.1 Dogs
- 7.2.2 Cats
- 7.2.3 Horses
- 7.2.4 Other Companion Animals
7.3 Livestock Animal
- 7.3.1 Cattle
- 7.3.2 Swine
- 7.3.3 Poultry
- 7.3.4 Sheep & Goats

Chapter 8 Animal Antibiotics and Antimicrobials Market Size and Forecast, By Region (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe

.8.3.1. Germany

8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe

8.4 Asia Pacific

.8.4.1. Japan

8.4.2 China
8.4.3 India
8.4.4 Australia and New Zealand
8.4.5 South Korea
8.4.6 Rest of Asia pacific

8.5 Latin America

.8.5.1. Brazil

8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America

8.6 MEA

.8.6.1. South Africa

8.6.2 Saudi Arabia
8.6.3 Turkey
8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Zoetis Inc.
9.2 Merck & Co., Inc.
9.3 Elanco Animal Health Incorporated
9.4 Boehringer Ingelheim International GmbH
9.5 Ceva Sante Animale
9.6 Virbac
9.7 Vetoquinol
9.8 Bayer AG
9.9 Novartis AG
9.10 Eli Lilly And Company
9.11 Sanofi
9.12 Arthrex